TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SanBio Co ( (JP:4592) ) has issued an update.
SanBio Co., Ltd. has announced the determination of issue price and other details for its new shares through an international offering, aiming to raise approximately 14,202 million yen. The funds will be used primarily for clinical trials and infrastructure development for its AKUUGO® and SB623 programs, enhancing its market position in Japan and the U.S.
The most recent analyst rating on (JP:4592) stock is a Sell with a Yen1010.00 price target. To see the full list of analyst forecasts on SanBio Co stock, see the JP:4592 Stock Forecast page.
More about SanBio Co
SanBio Co., Ltd. operates in the biotechnology industry, focusing on the development and commercialization of regenerative cell medicines. The company is known for its innovative therapies targeting neurological conditions, with a market focus on Japan and the United States.
Average Trading Volume: 2,779,301
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen204.9B
Find detailed analytics on 4592 stock on TipRanks’ Stock Analysis page.